Adage Capital Partners Gp, L.L.C. Biotechnology

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ACAD Acadia Pharmaceuticals Inc	$4.12B	$13 Million 0.02% of portfolio	603,800	Q2 2025 New
BBIO Bridge Bio Pharma, Inc.	$7.28B	$13 Million 0.02% of portfolio	301,361	Q2 2025 Reduced 41.66%
IMVT Immunovant, Inc.	$3.55B	$12.8 Million 0.02% of portfolio	463,600	Q2 2025 Added 2,086.79%
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$12.4 Million 0.02% of portfolio	243,000	Q2 2025 Reduced 29.57%
ATAI Atai Life Sciences N.V.	$685M	$11.9 Million 0.02% of portfolio	5,434,782	Q2 2025 New
CMPX Compass Therapeutics, Inc.	$321M	$11.5 Million 0.02% of portfolio	4,424,868	Q2 2025 Added 11.32%
URGN Uro Gen Pharma Ltd.	$437M	$11.4 Million 0.02% of portfolio	830,000	Q2 2025 Reduced 35.0%
TSHA Taysha Gene Therapies, Inc.	$141M	$11.2 Million 0.02% of portfolio	4,839,000	Q2 2025 New
BGNE Bei Gene, Ltd.	$23.5B	$8.84 Million 0.02% of portfolio	39,000	Q1 2025 New
ABUS Arbutus Biopharma Corp	$510M	$7.96 Million 0.01% of portfolio	2,575,941	Q2 2025 Added 63.45%
KOD Kodiak Sciences Inc.	$443M	$7.67 Million 0.01% of portfolio	2,055,707	Q2 2025 Added 55.06%
CORT Corcept Therapeutics Inc	$7.88B	$7.06 Million 0.01% of portfolio	96,172	Q2 2025 New
BPMC Blueprint Medicines Corp	$7.73B	$6.41 Million 0.01% of portfolio	50,000	Q2 2025 New
TERN Terns Pharmaceuticals, Inc.	$246M	$4.77 Million 0.01% of portfolio	1,280,000	Q2 2025 New
ATXS Astria Therapeutics, Inc.	$101M	$4.69 Million 0.01% of portfolio	875,000	Q2 2025 Added 48.76%
CRDF Cardiff Oncology, Inc.	$105M	$4.48 Million 0.01% of portfolio	1,423,000	Q2 2025 Reduced 1.52%
ORIC Oric Pharmaceuticals, Inc.	$377M	$3.71 Million 0.01% of portfolio	365,400	Q2 2025 New
STTK Shattuck Labs, Inc.	$32.2M	$3.69 Million 0.01% of portfolio	4,675,000	Q4 2024 Added 61.21%
SANA Sana Biotechnology, Inc.	$592M	$1.92 Million 0.0% of portfolio	702,000	Q2 2025 New
PEPG Pep Gen Inc.	$28.8M	$1.5 Million 0.0% of portfolio	1,350,000	Q1 2025 Added 68.75%
STRO Sutro Biopharma, Inc.	$40.7M	$1.42 Million 0.0% of portfolio	2,000,000	Q4 2024 Reduced 11.12%
TARA Protara Therapeutics, Inc.	$34.6M	$1.21 Million 0.0% of portfolio	400,000	Q2 2025 New
IKNA Ikena Oncology, Inc.	$50M	$1.07 Million 0.0% of portfolio	800,000	Q4 2024 Reduced 19.02%
IMUX Immunic, Inc.	$26M	$979,000 0.0% of portfolio	1,398,600	Q4 2024 Reduced 75.0%
BMEA Biomea Fusion, Inc.	$48.3M	$900,000 0.0% of portfolio	500,000	Q4 2024 Reduced 44.44%
VERU Veru Inc.	$254M	$580,000 0.0% of portfolio	1,000,000	Q1 2025 Reduced 56.52%
OVID Ovid Therapeutics Inc.	$38.7M	$379,000 0.0% of portfolio	1,150,000	Q1 2025 Added 15.0%
APLT Applied Therapeutics Inc.	$21.1M	$375,000 0.0% of portfolio	1,211,629	Q2 2025 Reduced 38.23%
CCCC C4 Therapeutics, Inc.	$110M	$286,000 0.0% of portfolio	200,000	Q2 2025 Reduced 87.1%
IFRX Infla Rx N.V.	$36.7M	$261,000 0.0% of portfolio	331,113	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,728,000	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.